With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert outsourcing partners to meet growing demand for complex fill and finish solutions. Vetter, a global contract development and manufacturing organization (CDMO) is investing in additional capacity to meet that growing global demand with the purchase of a clinical manufacturing site located in Austria.   As the healthcare environment continues to evolve, the global shift ...